Jan 18, 2019 247 Transfer Agreement FRBP. Transfer Agreement 3001 (e) 1 Transferors: Metastrat, Inc. (Amount $39,582.50) To Argo Partners filed by Matthew Alexander Gold on behalf of Argo Partners. (Gold, Matthew) (Entered: 01/18/2019) Jan 18, 2019 248 Transfer Agreement FRBP. Transfer Agreement 3001 (e) 1 Transferors: Mirador Global LP (Amount $15,000.00) To Argo Partners filed by Matthew Alexander Gold on behalf of Argo Partners. (Gold, Matthew) (Entered: 01/18/2019) Jan 18, 2019 249 Transfer Agreement FRBP. Transfer Agreement 3001 (e) 1 Transferors: Avanti Polar Lipids (Amount $5,000.00) To Argo Partners filed by Matthew Alexander Gold on behalf of Argo Partners. (Gold, Matthew) (Entered: 01/18/2019) Jan 18, 2019 Receipt of Transfer Agreement FRBP 3001(e) (CLAIMS AGENT CASES ONLY)( 18-14010-jlg) [claims,transclm] ( 25.00) Filing Fee. Receipt number A12986332. Fee amount 25.00. (Re: Doc # 247) (U.S. Treasury) (Entered: 01/18/2019) Jan 18, 2019 Receipt of Transfer Agreement FRBP 3001(e) (CLAIMS AGENT CASES ONLY)( 18-14010-jlg) [claims,transclm] ( 25.00) Filing Fee. Receipt number A12986332. Fee amount 25.00. (Re: Doc # 248) (U.S. Treasury) (Entered: 01/18/2019) Jan 18, 2019 Receipt of Transfer Agreement FRBP 3001(e) (CLAIMS AGENT CASES ONLY)( 18-14010-jlg) [claims,transclm] ( 25.00) Filing Fee. Receipt number A12986332. Fee amount 25.00. (Re: Doc # 249) (U.S. Treasury) (Entered: 01/18/2019) Jan 22, 2019 250 Third Interim Order signed on 1/22/2019: (I) Authorizing The Debtors To Obtain Postpetition Financing, (II) Authorizing The Debtors To Use Cash Collateral, (III) Granting Liens And Providing Superpriority Administrative Expense Status, (IV) Granting Adequate Protection, (V) Modifying The Automatic Stay, (VI) Scheduling A Final Hearing, And (VII) Granting Related Relief. (related document(s)15, 113, 50) Final hearing to be held on 2/21/2019 at 11:00 AM at Courtroom 601 (JLG) (Rodriguez, Willie) (Entered: 01/22/2019) Jan 22, 2019 251 Notice of Hearing /Notice of Omnibus Hearing Scheduled for February 21, 2019 at 11:00 a.m. filed by Lisa Laukitis on behalf of Synergy Pharmaceuticals Inc.. with hearing to be held on 2/21/2019 at 11:00 AM at Courtroom 601 (JLG) (Laukitis, Lisa) (Entered: 01/22/2019) Jan 22, 2019 252 Supplemental Reply to Motion /Supplemental Reply to U.S. Trustee Objection and in Support of Debtors' Application for Entry of an Order (I) Authorizing the Employment and Retention of Centerview Partners LLC as Investment Banker and Financial Advisor to the Debtors Effective Nunc Pro Tunc to the Petition Date, (II) Approving the Terms of the Centerview Engagement Letter, (III) Waiving Certain Time-Keeping Requirements, and (IV) Granting Related Relief (related document(s)135) filed by Albert Togut on behalf of Synergy Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1: Second Supplemental Greene Declaration # 2 Exhibit 2: Comparable Retention Approvals Chart) (Togut, Albert) (Entered: 01/22/2019) Jan 23, 2019 Pending Deadlines Terminated: Schedules A/B,D,E/F,G,H, and Summary of Schedules. (Rodriguez, Willie) (Entered: 01/23/2019)